Results 41 to 50 of about 14,407 (150)

Research advances of idiopathic membranous nephropathy with non-nephrotic range proteinuria

open access: yesLinchuang shenzangbing zazhi, 2022
Membranous nephropathy, an autoimmune kidney disease, is one of the major causes of nephrotic syndrome. However, not all patients with membranous nephropathy present with nephrotic syndrome and some of them develop non-nephrotic range proteinuria (24 ...
Sun Jing, Du Xuan-yi
doaj  

Anti-glomerular basement membrane disease superimposed on membranous nephropathy: a case report and review of the literature

open access: yesJournal of Medical Case Reports, 2010
Introduction Anti-glomerular basement membrane disease is a rare autoimmune disorder characterized by pulmonary hemorrhage, crescentic glomerulonephritis and the presence of circulating anti-glomerular basement membrane antibodies.
Nivera Noel   +2 more
doaj   +1 more source

Diagnosis of membranous nephropathy with Anti-GBM glomerulonephritis: a case series report

open access: yesBMC Nephrology
Background The concomitant occurrence of membranous nephropathy and anti-glomerular basement (anti-GBM) disease has been previously described but is extremely rare.
Ge Liu   +5 more
doaj   +1 more source

Distribution of glomerular diseases in Taiwan: preliminary report of National Renal Biopsy Registry–publication on behalf of Taiwan Society of Nephrology

open access: yesBMC Nephrology, 2018
Background Despite the development of biomarkers and noninvasive imaging tools, biopsy remains the only method for correctly diagnosing patients with unexplained hematuria, proteinuria and renal failure.
Hsien-Fu Chiu   +4 more
doaj   +1 more source

Advances in the pathogenesis and clinical applications of PLA2R-associated membranous nephropathy

open access: yesLinchuang shenzangbing zazhi
Membranous nephropathy is one of the main pathological types of nephrotic syndrome. PLA2R(phospholipase A2 receptor)associated membranous nephropathy is the predominant type of primary membranous nephropathy, also known as idiopathic membranous ...
Sun Miao-xin   +9 more
doaj  

Value of M-type phospholipase A2 receptor in clinical diagnosis and treatment of membranous nephropathy:recent advances and current controversies

open access: yesLinchuang shenzangbing zazhi, 2021
The sensitivity of serum anti-M-type phospholipase A2 receptor antibodies(anti-PLA2 R Abs)is 70%~80% in idiopathic membranous nephropathy and the specificity over 95%.This article reviewed the latest research advances on the pathogenesis,diagnosis ...
Wang Hui   +3 more
doaj  

Anti Phospholipase A2 Receptor 1 Antibodies and Membranous Nephropathy Recurrence After Kidney Transplantation

open access: yesKidney International Reports
Introduction: Membranous nephropathy can lead to end-stage kidney disease, for which kidney transplantation is the preferred therapy. However, the disease often relapses, which can impact allograft survival.
Marion Cremoni   +35 more
doaj   +1 more source

Membranous Nephropathy and Pulmonary Tuberculosis: An Uncommon Combination: Case Report

open access: yesEuropean Medical Journal
It is imperative to evaluate for secondary causes of membranous glomerulonephritis, from infections such as hepatitis B and C, viruses and parasites, autoimmune diseases like systemic lupus erythematosus, and other neoplasms.
Puneet Bhuwania   +2 more
doaj   +1 more source

Membranous glomerulopathy and treatment with Acthar®: a case study

open access: yesInternational Journal of Nephrology and Renovascular Disease, 2013
Myra June WatsonNephrology/Hypertension Associates, Columbia, MO, USAAbstract: Treatment options for refractory membranous nephropathy are limited. Herein we describe the case of a 46-year-old white male with membranous nephropathy who progressed during ...
Watson MJ
doaj  

Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies

open access: yesKidney International Reports
Introduction: Although rituximab has significantly improved outcomes for patients with membranous nephropathy, response to treatment is not universal and drug resistance can occur.
Maxime Teisseyre   +19 more
doaj   +1 more source

Home - About - Disclaimer - Privacy